nūhou

1. Johnson & Johnson
Ua hoʻokumu ʻia ʻo Johnson & Johnson ma 1886 a ʻo ia ke keʻena nui ma New Jersey a me New Brunswick, USA.ʻO Johnson & Johnson kahi hui biotechnology multinational, a me ka mea hana i nā huahana i hoʻopili ʻia e nā mea kūʻai aku a me nā mea lapaʻau.Hoʻolaha a kūʻai aku ka hui ma mua o 172 mau lāʻau lapaʻau ma ʻAmelika Hui Pū ʻIa.Hoʻopili nā māhele lāʻau lapaʻau i nā maʻi infectious, immunology, oncology a me neuroscience.I ka makahiki 2015, ua loaʻa iā Qiangsheng he 126,500 mau limahana, ka huina waiwai o $131 biliona, a me ke kūʻai ʻana o $ 74 biliona.

2. Roche
Ua hoʻokumu ʻia ʻo Roche Biotech ma Switzerland i ka makahiki 1896. Loaʻa iā ia nā huahana biopharmaceutical 14 ma ka mākeke a hoʻolilo iā ia iho ʻo ia ka hoa hana biotech nui loa o ka honua.Ua loaʻa iā Roche ka huina kūʻai o $ 51.6 biliona ma 2015, kahi waiwai mākeke o $ 229.6 biliona, a me nā limahana 88,500.

3. ʻO Novartis
Ua hoʻokumu ʻia ʻo Novartis ma 1996 mai ka hui ʻana o Sandoz a me Ciba-Geigy.Hana ka hui i nā lāʻau lapaʻau, generics a me nā huahana mālama maka.Hoʻopili ka ʻoihana o ka hui i nā mākeke ulu o nā mākeke e kū mai ana ma Latin America, Asia a me ʻApelika.He alakaʻi honua ʻo Novartis Healthcare i ka hoʻomohala ʻana a me ka mālama mua, a me ka hoʻolaha ʻana i nā lāʻau lapaʻau kūikawā.Ma 2015, ua ʻoi aku ka nui o nā limahana o Novartis ma mua o 133,000 ma ka honua holoʻokoʻa, nā waiwai o $ 225.8 biliona, a me nā kūʻai aku o $ 53.6 biliona.

4. Pfizer
ʻO Pfizer kahi hui biotechnology honua i hoʻokumu ʻia ma 1849 a ʻo ke keʻena nui ma New York City, USA.Ua kūʻai ʻo ia iā Botox Maker Allergan no $ 160 miliona ma 2015, ʻo ia ka hana nui loa i ka lāʻau lapaʻau.Ma 2015, loaʻa iā Pfizer nā waiwai o $ 169.3 biliona a me nā kūʻai aku o $ 49.6 biliona.

5. Merck
Ua hoʻokumu ʻia ʻo Merck i ka makahiki 1891 a aia ʻo ia ma New Jersey, USA.He hui honua ia e hana ana i nā lāʻau lapaʻau, biotherapeutics, nā lāʻau lapaʻau, a me ke olakino holoholona a me nā huahana mea kūʻai aku.Ua hoʻolilo nui ʻo Merck i ka hakakā ʻana i nā maʻi maʻi e kū mai ana, me ka Ebola.I ka makahiki 2015, ua loaʻa iā Merck ka nui o ka mākeke ma kahi o $150 biliona, kūʻai aku he $42.2 biliona, a me nā waiwai he $98.3 biliona.​

6. ʻEpekema Gileada
ʻO Gileada Sciences kahi hui biopharmaceutical e pili ana i ka noiʻi i hoʻolaʻa ʻia i ka ʻike, hoʻomohala ʻana a me ka hoʻolaha ʻana i nā lāʻau lapaʻau hou, i hoʻokumu ʻia ma Kaleponi, USA.I ka makahiki 2015, ua loaʻa iā Gileada ʻepekema he $34.7 biliona i nā waiwai a me $25 biliona ma ke kūʻai aku.

7. Novo Nordisk
ʻO Novo Nordisk kahi hui biotechnology multinational i hoʻokumu ʻia ma Denmark, me nā hale hana ma 7 mau ʻāina a me 41,000 mau limahana a me nā keʻena ma 75 mau ʻāina a puni ka honua.Ma 2015, loaʻa iā Novo Nordisk nā waiwai o $ 12.5 biliona a kūʻai aku i $ 15.8 biliona.

8. Amgen
ʻO Amgen, ke keʻena nui ma Thousand Oaks, Kaleponi, hana i nā lāʻau lapaʻau a nānā i ka hoʻomohala ʻana i nā lāʻau lapaʻau hou e pili ana i ka holomua o ka molecular a me ka cellular biology.Hoʻomohala ka hui i nā lāʻau lapaʻau no ka maʻi iwi, ka maʻi kīkī, ka maʻi rheumatoid a me nā maʻi koʻikoʻi ʻē aʻe.Ma 2015, loaʻa iā Amgen nā waiwai o $ 69 biliona a kūʻai aku i $ 20 biliona.

9. Bristol-Myers Squibb
ʻO Bristol-Myers Squibb (Bristol) kahi hui biotechnology i hoʻokumu ʻia ma New York City, United States.Ua kūʻai ʻo Bristol-Myers Squibb i iPierian no $ 725 miliona ma 2015 a me Flexus Biosciences no $ 125 miliona ma 2015. Ma 2015, loaʻa iā Bristol-Myers Squibb nā waiwai o $ 33.8 biliona a kūʻai aku i $ 15.9 biliona.

10. Sanofi
ʻO Sanofi kahi hui hui lāʻau lapaʻau Farani i hoʻokumu ʻia ma Paris.Hoʻolaha ka hui i nā lāʻau lapaʻau kanaka, nā hopena maʻi diabetes a me ka mālama ola kino, nā lāʻau lapaʻau hou a me nā huahana ʻē aʻe.Hana ʻo Sanofi ma mua o 100 mau ʻāina a puni ka honua, me ʻAmelika Hui Pū ʻIa, me kāna keʻena poʻo US ma Bridgewater, New Jersey.I ka makahiki 2015, ua loaʻa iā Sanofi ka waiwai o $177.9 biliona a me ke kūʻai aku he $44.8 biliona.